Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT - About
TRNS 
Transcat Inc (TRNS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: TRNS (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
AI Based Fundamental Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Analysis of Past Performance
Type Stock | Historic Profit -56.98% | Avg. Invested days 29 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 04/01/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 690.39M USD | Price to earnings Ratio 39.24 | 1Y Target Price 100.15 |
Price to earnings Ratio 39.24 | 1Y Target Price 100.15 | ||
Volume (30-day avg) 77631 | Beta 0.66 | 52 Weeks Range 67.56 - 147.12 | Updated Date 04/1/2025 |
52 Weeks Range 67.56 - 147.12 | Updated Date 04/1/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 1.89 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 6.22% | Operating Margin (TTM) 4.31% |
Management Effectiveness
Return on Assets (TTM) 3.77% | Return on Equity (TTM) 6.78% |
Valuation
Trailing PE 39.24 | Forward PE 34.48 | Enterprise Value 753582641 | Price to Sales(TTM) 2.54 |
Enterprise Value 753582641 | Price to Sales(TTM) 2.54 | ||
Enterprise Value to Revenue 2.77 | Enterprise Value to EBITDA 19.47 | Shares Outstanding 9309470 | Shares Floating 9035492 |
Shares Outstanding 9309470 | Shares Floating 9035492 | ||
Percent Insiders 2.42 | Percent Institutions 97.45 |
Analyst Ratings
Rating 4.4 | Target Price 121.2 | Buy 1 | Strong Buy 3 |
Buy 1 | Strong Buy 3 | ||
Hold 1 | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Transcat Inc
Company Overview
History and Background
Transcat, Inc. was founded in 1964 as a distributor of test and measurement instruments. Over time, it has evolved into a leading provider of calibration, repair, inspection, and laboratory instrument services, as well as a distributor of test, measurement, and control instrumentation.
Core Business Areas
- Service Segment: Provides calibration, repair, inspection, and laboratory instrument services across a broad range of industries including life sciences, aerospace & defense, and general manufacturing.
- Distribution Segment: Sells and rents a broad range of test, measurement, and control instruments.
Leadership and Structure
Lee Rudow is the current President and CEO. The company has a typical corporate structure with a Board of Directors and various functional departments.
Top Products and Market Share
Key Offerings
- Calibration Services: Transcat's core offering, providing accredited calibration services for various instruments. The company doesn't specify a specific market share for this product. Competitors include Keysight Technologies (KEYS), Tektronix (owned by Danaher), and Fluke Corporation (owned by Fortive).
- Test and Measurement Instrument Distribution: Transcat distributes a wide range of instruments from various manufacturers. The company doesn't specify a specific market share for this product. Competitors include TestEquity (owned by Azenta, Inc.), Newark Electronics (owned by Premier Farnell), and Digi-Key Electronics.
Market Dynamics
Industry Overview
The calibration and testing services industry is driven by regulatory compliance, technological advancements, and the increasing complexity of equipment. The test and measurement instrument distribution market is driven by technological innovation, research and development and manufacturing activity.
Positioning
Transcat positions itself as a single-source provider of calibration and distribution solutions, offering a broad range of services and products. They aim to differentiate through their accreditation, technical expertise, and customer service.
Total Addressable Market (TAM)
The global calibration services market is estimated at around $20 billion USD. The global test and measurement equipment market is estimated at about $35 billion USD. Transcat is positioned to capture a portion of this market through its service and distribution segments.
Upturn SWOT Analysis
Strengths
- Strong brand reputation
- Accredited calibration services
- Broad product and service offering
- Experienced technical team
- Extensive geographic reach
Weaknesses
- Dependence on key suppliers
- Potential for commoditization of services
- Exposure to economic cycles
- Potential impact of large supply chain players
- Small cap stock volatility
Opportunities
- Expansion into new geographic markets
- Acquisition of complementary businesses
- Increased demand for calibration services due to stricter regulations
- Growing demand for remote calibration services
- Further penetration in life science sector
Threats
- Economic downturn
- Increased competition
- Technological obsolescence
- Changes in regulations
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- KEYS
- FTV
- AZTA
- FLIR
Competitive Landscape
Transcat has a strong focus on regulated industries and offers a comprehensive service offering. Its competitors have broader product lines or different geographic strengths.
Major Acquisitions
Integra Technologies
- Year: 2023
- Acquisition Price (USD millions): 27.5
- Strategic Rationale: Expanded Transcat's offerings into biopharmaceutical validation and metrology services.
Growth Trajectory and Initiatives
Historical Growth: Transcat has historically grown through organic expansion and acquisitions.
Future Projections: Future growth projections are based on analyst estimates. These are dynamic and not included here.
Recent Initiatives: Recent strategic initiatives would need to be reviewed from company statements and reports.
Summary
Transcat is a well-established company in the calibration and test equipment market with a solid reputation. Their strengths lie in their comprehensive service offerings and focus on regulated industries. They face risks from economic cycles and competition, and their growth will depend on strategic acquisitions and expansion into new markets.
Similar Companies
- KEYS
- FLIR
- FTV
Sources and Disclaimers
Data Sources:
- Company Filings (10-K, 10-Q)
- Investor Presentations
- Analyst Reports
- Industry Research Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Transcat Inc
Exchange NASDAQ | Headquaters Rochester, NY, United States | ||
IPO Launch date 1990-03-27 | President, CEO & Director Mr. Lee D. Rudow | ||
Sector Industrials | Industry Industrial Distribution | Full time employees 1104 | Website https://www.transcat.com |
Full time employees 1104 | Website https://www.transcat.com | ||
Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.
Upturn is now on iOS and Android!
Experience Upturn on your mobile. Install it now!
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.